Activated C-Jun transcription factors bind to AP-1 sites, thereby promoting the expression of pro-inflammatory factors (e.g., TNFα, IL1β, IL6, etc.), which play a key role in impaired glucose tolerance and insulin resistance by HFD-induced obesity [85]. Here, IL1B is linked to Impaired glucose tolerance.